News & Opinion

» cancer and opinion

Covering the life sciences inside and out

Most Recent

image: Cancer-Fighting Virus

Cancer-Fighting Virus

By | June 13, 2012

A small patient trial offers hope that cancer-killing viruses might be a viable therapy after all.

3 Comments

image: Opinion: What’s Wrong with COI?

Opinion: What’s Wrong with COI?

By | June 12, 2012

Financial “conflicts of interest” should not be so quickly condemned. Industry relationships are unequivocally beneficial.

0 Comments

image: TB Vax for Bladder Cancer

TB Vax for Bladder Cancer

By | June 6, 2012

How the bacteria found in a tuberculosis vaccine can improve the outcome of bladder cancer treatment

9 Comments

image: Opinion: Justice Delayed, Health Denied

Opinion: Justice Delayed, Health Denied

By | June 4, 2012

African justice systems must change to help curb HIV and tuberculosis transmission in prisons.

12 Comments

image: Trials Overlook Cancer Spread

Trials Overlook Cancer Spread

By | May 30, 2012

One cancer researcher says that by focusing solely on stalling cancer growth, clinical trials are failing some potentially life-saving drugs that prevent metastasis.

0 Comments

image: Opinion: Pressured to Commercialize

Opinion: Pressured to Commercialize

By | May 28, 2012

Is the push for science to save the still flailing economy a threat to scientific research?

5 Comments

image: The Aging and Inflammation Link

The Aging and Inflammation Link

By | May 24, 2012

A protein that keeps the immune response in check leads a double life as an anti-aging factor.

4 Comments

image: Genome Digest

Genome Digest

By | May 22, 2012

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: Opinion: Saving Species through Economics

Opinion: Saving Species through Economics

By | May 21, 2012

Successful conservation depends on an economy that doesn’t incentivize destruction of species and habitats.

4 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Popular Now

  1. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  2. Pubic Hair Grooming Linked to STI Risk
    The Nutshell Pubic Hair Grooming Linked to STI Risk

    Observational study suggests pubic hair grooming correlates with heightened risk of acquiring sexually transmitted infections, although causation remains unclear.

  3. Gut Microbes Linked to Neurodegenerative Disease
  4. Toward Treating Alzheimer’s Disease with Brain Waves
Rockland